Kindstar Globalgene Technology (HKSE:09960) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 28, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Kindstar Globalgene Technology (HKSE:09960) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Kindstar Globalgene Technology Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.

Executives

Orbimed Asia Partners Iv, L.p.	2101 Beneficial owner
Orbimed Asia Gp Iv, L.p.	2201 Interest of corporation controlled by you
Orbimed Advisors Iv Limited	2201 Interest of corporation controlled by you
Cpe Holdings International Limited	2201 Interest of corporation controlled by you
Cpechina Fund Iii, L.p.	2201 Interest of corporation controlled by you
Cpe Holdings Limited	2201 Interest of corporation controlled by you
Cpe Funds Iii Limited	2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited	2101 Beneficial owner
Jackson Hole Trust Company
Huang Bo
Huang Shiang	2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Huang Zuie-chin	2101 Beneficial owner
Tu Zanbing
Kastle Limited	2301 Trustee

Kindstar Globalgene Technology Headlines

No Headlines